P3 Health Partners
PIII
65 hedge funds and large institutions have $36.6M invested in P3 Health Partners in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 8 closing their positions.
178% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 9
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
5% more funds holding
Funds holding: 62 → 65 (+3)
0.06% less ownership
Funds ownership: 0.49% → 0.44% (-0.06%)
56% less capital invested
Capital invested by funds: $83.7M → $36.6M (-$47.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$5.88M |
| 2 |
Millennium Management
New York
|
+$1.53M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.35M |
| 4 |
HF
HRT Financial
New York
|
+$871K |
| 5 |
Renaissance Technologies
New York
|
+$615K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.37M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.01M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$2.49M |
| 4 |
AR
Advisory Research
Chicago,
Illinois
|
-$349K |
| 5 |
E
Ergoteles
New York
|
-$132K |
PIII Hedge Fund Activity: Q3 2023 in Review
65 of the 6,303 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q3 2023, worth a combined $36.6M — down 56% from $83.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new PIII positions and 8 closed out — a net gain of 3 holders — while 25 added to existing stakes and 9 trimmed.
The largest buyer was Ameriprise, adding an estimated $5.88M. The largest seller was Fidelity Investments, cutting an estimated $9.37M.
- 65 institutional investors held P3 Health Partners (PIII) as of Q3 2023, up from 62 in Q2 2023.
- Funds reported $36.6M of P3 Health Partners stock for Q3 2023, down 56% quarter-over-quarter.
- 11 funds opened new P3 Health Partners positions in Q3 2023 and 8 closed out, a net change of +3 holders.
- The largest P3 Health Partners buyer in Q3 2023 was Ameriprise, an estimated $5.88M added.
- The largest P3 Health Partners seller in Q3 2023 was Fidelity Investments, an estimated $9.37M sold.
Based on aggregated 13F filings for Q3 2023.